Skip to content

Muscle Evaluation Using Ultrasound in the Critically Ill

Muscle Evaluation Using Ultrasound in the Critically Ill : ULTRAMUSCLE Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03550222
Acronym
ULTRAMUSCLE
Enrollment
100
Registered
2018-06-08
Start date
2018-01-30
Completion date
2019-12-30
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, ICU Acquired Weakness

Keywords

Diaphragmatic dysfunction, Mechanical Ventilation, ICU acquired weakness, Weaning, Skeletal muscles, Respiratory muscles

Brief summary

Critical illness is associated with ICU acquired weakness and diaphragmatic dysfunction. Ultrasound can evaluate the muscle mass non invasively and provides the ability for a muscle follow up during and after the ICU stay. Magnetic stimulation of the phrenic nerves and the measure of the end expiratory tracheal pressure with an occlusion valve allows to evaluate the diaphragm force production in mechanically ventilated patients. The aim of the present study is to constitute an image bank and to describe the muscle mass and function recovery in critically ill patients.

Detailed description

Critical illness is associated with ICU acquired weakness and diaphragmatic dysfunction. Ultrasound can evaluate the muscle mass non invasively and provides the ability for a muscle follow up during and after the ICU stay. Magnetic stimulation of the phrenic nerves and the measure of the end expiratory tracheal pressure with an occlusion valve allows to evaluate the diaphragm force production in mechanically ventilated patients. The aim of the present study is to constitute an image bank and to describe the mass and function recovery in critically ill patients. Ultrasound and clinical data will be collected and analysed during the ICU stay.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill patients with at least one organ failure defined, organ failure being defined by a SOFA equal or above 3 for the organ, and an expected duration of ICU stay equal of above 3 days

Exclusion criteria

\- Pregnancy, age below 18, absence of consent

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound characteristics of the quadricepsSince admission at day 0 and measured repetitively by 48 hours untildischarge from ICU or date of death from any cause, whichever came first, assessed up to day 28Changes in ultrasound characteristics of the quadriceps : cross sectional area of quadriceps (cm2)

Other

MeasureTime frameDescription
Ultrasound characteristics of the bicepsSince admission at day 0 and measured repetitively by 48 hours untildischarge from ICU or date of death from any cause, whichever came first, assessed up to day 28Changes in ultrasound characteristics of the biceps : thickness of the biceps (mm)
Ultrasound characteristics of the diaphragmSince admission at day 0 and measured repetitively by 48 hours untildischarge from ICU or date of death from any cause, whichever came first, assessed up to day 28Ultrasound characteristics of the diaphragm : thickness (mm)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026